FUJIFILM Holdings Co. (OTCMKTS:FUJIY) Sees Significant Growth in Short Interest

FUJIFILM Holdings Co. (OTCMKTS:FUJIYGet Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 56,600 shares, a growth of 116.9% from the September 15th total of 26,100 shares. Based on an average trading volume of 173,900 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised FUJIFILM from a “hold” rating to a “buy” rating in a report on Tuesday, August 20th.

Check Out Our Latest Analysis on FUJIFILM

FUJIFILM Stock Up 0.1 %

OTCMKTS:FUJIY traded up $0.01 during trading hours on Friday, hitting $12.70. The company’s stock had a trading volume of 63,163 shares, compared to its average volume of 90,258. The stock has a market capitalization of $31.60 billion, a P/E ratio of 17.92, a price-to-earnings-growth ratio of 2.35 and a beta of 0.42. The stock has a fifty day moving average of $12.72 and a 200-day moving average of $11.69. The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.04. FUJIFILM has a 52-week low of $8.99 and a 52-week high of $13.88.

FUJIFILM (OTCMKTS:FUJIYGet Free Report) last posted its earnings results on Wednesday, August 7th. The technology company reported $0.16 EPS for the quarter. The firm had revenue of $4.80 billion for the quarter. FUJIFILM had a return on equity of 7.96% and a net margin of 8.19%. On average, equities analysts forecast that FUJIFILM will post 0.7 earnings per share for the current year.

About FUJIFILM

(Get Free Report)

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.

See Also

Receive News & Ratings for FUJIFILM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FUJIFILM and related companies with MarketBeat.com's FREE daily email newsletter.